SecBot SecBot
EFFECT ·Filed Jun 18, 2026

PCSC

Perceptive Capital Solutions Corp
NEUTRAL
Impact 5/10
Horizonweeks Processed4mo ago SEC9999999995-26-002041
IPO/offering going effective
Actionable Insight • Neutral

The S-4 effectiveness is a key step toward closing the de-SPAC merger. Monitor for the shareholder vote date and any PIPE or redemption announcements. Post-merger, Freenome's stock (likely new ticker) will trade on Nasdaq. The SPAC's trust cash and any PIPE will determine the combined company's initial market cap.

DirectionNeutral
Confidencemedium
Horizonweeks
Latest settled — T+20d ⚠ clustered
PCSC ▲ +8.21% at T+20d
NEUTRAL call +8.21% · α vs SPY +7.67% · entry $11.09 → $12.00
Next anchor: T+60d due 6w ago
Entry = T+0 close
Jun 18, 2026
via day close
T+1d
-0.72%
call -0.72% · α -0.41%
$11.01
settled 4mo ago
T+5d
-1.17%
call -1.17% · α +0.49%
$10.96
settled 4mo ago
T+20d
+8.21%
call +8.21% · α +7.67%
$12.00
settled 3mo ago
T+60d
Pending
due 6w ago

Price Chart

Loading chart...

Executive Summary

The SEC declared effective the S-4 registration statement for the business combination between Perceptive Capital Solutions Corp (a SPAC) and Freenome Holdings, Inc. This clears the regulatory path for the de-SPAC merger, allowing Freenome to become a publicly traded company. The effectiveness date is June 17, 2026.

Key Facts

  • SEC declared effective the S-4 registration for the business combination between Perceptive Capital Solutions Corp (SPAC) and Freenome Holdings, Inc.
  • Effectiveness date: June 17, 2026.
  • Freenome Holdings is a medical laboratory services company based in South San Francisco, CA.
  • The filing does not disclose the specific terms of the merger, including valuation or PIPE size.

Financial Impact

No financial figures disclosed in the filing. The S-4 effectiveness is a procedural milestone for the de-SPAC merger.

dilutionenterprise value

Risk Factors

  • Shareholder redemptions could reduce the cash available to the combined company.
  • Post-merger dilution from the SPAC sponsor promote and any PIPE warrants.
  • Freenome is a pre-revenue or early-stage diagnostics company, carrying high execution risk.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-002041
Document: 9999999995-26-002041-index.html9999999995-26-002041
Document: 9999999995-26-002041.txt9999999995-26-002041
12 reports for PCSC
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for PCSC — sortable, filterable
TypeNow
Jul 22, 2026
13w ago
3
NEUTRAL ★ 3/10
$12.01awaiting T+5——
Jul 22, 2026
13w ago
3
NEUTRAL ★ 3/10
$12.01awaiting T+5——
Jul 20, 2026
14w ago
25-NSE
BEARISH ★ 9/10
$12.01awaiting T+5——
Jul 9, 2026
15w ago
425
BULLISH ★ 7/10
$10.90 $12.00▲ +10.09%▲ +10.22%—
Jul 9, 2026
15w ago
425 / 8-K
NEUTRAL ★ 4/10
$10.90 $12.00▲ +10.09%▲ +10.22%—
Jun 18, 2026
18w ago
425
NEUTRAL ★ 4/10
$11.01 $10.93▼ −0.73%▲ +1.34%—
Jun 18, 2026
18w ago
8-K
NEUTRAL ★ 5/10
$11.01 $10.93▼ −0.73%▲ +1.34%—
Jun 18, 2026
18w ago
EFFECT
NEUTRAL ★ 5/10
$11.09 $10.96▼ −1.17%▲ +0.49%—
Jun 11, 2026
19w ago
S-4/A
NEUTRAL ★ 4/10
$11.40 $11.09▼ −2.72%▼ −3.39%—
Jun 10, 2026
19w ago
425
NEUTRAL ★ 4/10
$11.27 $11.16▼ −0.98%▼ −1.41%—
Showing 10 of 12

US Market Status

Market Closed — Opens in 3h 23m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 18, 2026